BioSpace News Archive

Career Advice

Informational Interviews for Life Science Professionals

The idea is to have a conversation with someone holding a job like the one you’d like to have and perform informational interviews to ask all about what the job is like.

August 19, 2019

·

4 min read

·

Katharine Hansen, PhD

FDA

FDA Approves AbbVie’s Rinvoq, a Potential Successor to Humira

AbbVie’s JAK inhibitor Rinvoq was approved by the U.S. Food and Drug Administration for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.

August 19, 2019

·

3 min read

·

Alex Keown

Business

Colorado, Wyoming Ready for Biotech Jobs Boost with Potential Expansions

The American West could see some significant growth in the number of biotech jobs as companies are eying at least two states for expansions.

August 19, 2019

·

3 min read

·

Alex Keown

Switzerland overtakes Germany as Europe’s biggest drug delivery innovator, with the UK and France close behind

Innovation in drug delivery accelerating according to new Pharmapack Europe research

August 19, 2019

·

5 min read

Deals

Sernova Announces First Closing of Private Placement

Sernova Corp., a clinical-stage regenerative medicine company, is pleased to announce that it has completed a first closing of $2,333,500 of its non-brokered private placement, of which $64,000 was closed under the “Existing Shareholder Exemption.”

August 19, 2019

·

4 min read

Business

WuXi Biologics Reports Outstanding Interim Results

WuXi Biologics (Cayman) Inc. announced its unaudited interim results for the six months ended June 30, 2019.

August 19, 2019

·

12 min read

A novel T-cell subset associated with type 1 diabetes

A study conducted at the University of Eastern Finland demonstrated that a recently described T-cell subset, so-called peripheral T helper cells, may have a role in the development of type 1 diabetes.

August 19, 2019

·

3 min read

Policy

PhamaMar will submit NDA for lurbinectedin under accelerated approval in SCLC in the USA

PharmaMar announced that the FDA agreed with PharmaMar’s proposal to file for accelerated approval its New Drug Application (NDA) for lurbinectedin monotherapy for the treatment of second-line SCLC.

August 19, 2019

·

3 min read

New Insights Could Lead to More Control Over Opioid Addiction

Researchers at The Scripps Research Institute in Florida recently published a study in the journal Science describing a newly discovered biological system that manages how cells respond to exposure to opioids.

August 19, 2019

·

3 min read

·

Mark Terry

Deals

SpringWorks Sets Stage for $115 Million IPO

The company is seeking the funds to continue to drive the development of its lead candidates, nirogacestat, a gamma-secretase inhibitor for the treatment of desmoid tumors and PD-0325901, a MEK inhibitor for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas.

August 19, 2019

·

2 min read

·

Alex Keown